drugset / Trial / NCT01772056
Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children
Phase 3
Terminated
54 enrolled
Elena Rubio Gomis
Fundacion Investigación Hospital General Universitario de Valencia · collabInstituto de Salud Carlos III · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The relapsing nature of atopic dermatitis (AD) presents a challenge for its long-term treatment. Efficacy and safety of corticosteroids have been proven in the acute treatment of AD, but not its efficacy and security to reduce or prevent relapses. Objectives To investigate long-term management (16 weeks) of AD with fluticasone propionate (FP) 0,05% cream twice weekly in addition to an emollient (vehicle) after stabilization of an acute flare of AD with FP cream.
Timeline
- Start
- 2009-12
- Primary completion
- 2012-01
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 0.05 % | Topical |